Mathilda Claassen

Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa

Houriiyah Tegally, Monika Moir, Josie Everatt et al. · Nature Medicine · 2022 · 686 citations · Full text

Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens

Gert U. van Zyl, Tommy F. Liu, Mathilda Claassen et al. · PLoS ONE · 2013 · 66 citations · Full text

Clinical Experience With Severe Acute Respiratory Syndrome Coronavirus 2–Related Illness in Children: Hospital Experience in Cape Town, South Africa

Marieke M. van der Zalm, Juanita Lishman, Lilly M. Verhagen et al. · Clinical Infectious Diseases · 2020 · 50 citations · Full text

PROTEASE INHIBITOR RESISTANCE IN SOUTH AFRICAN CHILDREN WITH VIROLOGIC FAILURE

Gert U. van Zyl, Lize van der Merwe, Mathilda Claassen et al. · The Pediatric Infectious Disease Journal · 2009 · 46 citations

Breakthrough Infections with SARS-CoV-2 Omicron Variant Despite Booster Dose of mRNA Vaccine

Constanze Kuhlmann, Carla Konstanze Mayer, Mathilda Claassen et al. · SSRN Electronic Journal · 2021 · 42 citations · Full text